Middle East & Africa Home Infusion Therapy Market

The Middle East & Africa home infusion therapy market is expected to grow from US$ 1,284.92 million in 2022 to US$ 1,988.27 million by 2028. It is estimated to grow at a CAGR of 7.5% from 2022 to 2028.

Addressing Unmet Needs of Patients Suffering from Oncological and Hematological Conditions is Driving

Middle East & Africa Home Infusion Therapy Market

With a dramatic shift toward homecare during the COVID-19 pandemic, the pharmaceutical and medical industries are focusing on developing various types of drugs to be administered in homecare settings, through the combination of pumps and professional services. The past decades have witnessed a shift in the delivery of chemotherapy from the hospital inpatient setting to the hospital outpatient setting to the specialized community practice setting. Furthermore, with developments in healthcare, a homecare setting is likely to become the place of care for the infusion of chemotherapy drugs. Companies in the home infusion therapy market are working on expanding their business by focusing on the unmet needs of patients. Globally, ~380 marketed infusion drugs and an additional 160 drugs are currently in the Phase 3 of drug development; more than 70% of these have an oncology or hematology indication. Thus, with growing efforts to launch infusion therapies for providing treatment of cancer and IDA at home is likely to fuel the home infusion therapy market growth during the forecast period.

Middle East & Africa Home Infusion Therapy Market Overview 

The Middle East & Africa home infusion therapy market has been segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia is expected to account for the largest market share and is expected to develop moderately in the Middle East & Africa. The market growth is attributed to various factors, such as significant development in healthcare facilities, the awareness about the home healthcare, and the geographic expansion of market players. Moreover, the rising incidence of diabetes, gastrointestinal diseases, prevalence of malnutrition, increase in geriatric population, and increasing government initiatives for home infusion therapy are expected to boost the home infusion therapy market growth over the forecast period. Saudi Arabia is estimated to register a considerable growth rate in the home infusion therapy market in the coming years due to awareness programs initiated by healthcare service providers, public organizations, and government bodies to enhance the development of home infusion therapy. In the last few years, the private sector has been playing an important role in the healthcare system in Saudi Arabia, owing to the rising investments in the development of healthcare facilities and infrastructure in the country. The Government of Saudi Arabia launched the Saudi Vision 2030 program to reduce oil dependence and diversify other sectors, including healthcare. Under this program, the Health Sector Transformation Program aims to reconstruct the healthcare sector as a comprehensive, effective, and integrated health system based on the health of the individual. Also, the Saudi Arabia Ministry of Health provides home healthcare services to patients that require enteral nutrition, patients that suffer from diabetes, and patients who are administered with antibiotics.   

Middle East & Africa Home Infusion Therapy Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Home Infusion Therapy Strategic Insights

Strategic insights for the Middle East & Africa Home Infusion Therapy provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East & Africa Home Infusion Therapy Report Scope

Middle East & Africa Home Infusion Therapy Regional Insights

The geographic scope of the Middle East & Africa Home Infusion Therapy refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Middle East & Africa Home Infusion Therapy Market Segmentation

The Middle East & Africa home infusion therapy market is segmented into product, application, route of administration and country.

Based on product, the home infusion therapy market is segmented into infusion pumps, intravenous sets, IV cannulas, and needleless connectors. The home infusion therapy market segment is sub segmented into insulin pumps, elastomeric pumps, syringe pumps, and others. The infusion pumps segment held the largest market share in 2022.  

Based on application, the home infusion therapy market is segmented into enteral nutrition, anti-infective, endocrinology, hydration therapy, chemotherapy, specialty pharmaceuticals, and others. The anti-infective segment held the largest share of the market in 2022.

Based on route of administration, the home infusion therapy market is segmented into intramuscular, subcutaneously, and epidural. The intramuscular segment held the largest share of the market in 2022. 

Based on country, the Middle East & Africa home infusion therapy market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the market in 2022.  

B. Braun Melsungen AG; Baxter International Inc; Nipro Corp; Becton Dickinson and Co; Fresenius Kabi AG; ICU Medical Inc; JMS Co Ltd; Terumo Corp are the leading companies operating in the Middle East & Africa home infusion therapy market.